US Pharma MarketingThe post Schizophrenia research grapples with trial design hurdles in hunt for new treatments appeared first on Clinical Trials Arena.
Schizophrenia research grapples with trial design hurdles in hunt for new treatments
A sector plagued by drug failures is looking to optimise study methodology, site selection, and patient recruitment. A sector plagued by drug failures is looking to optimise study methodology, site selection, and patient recruitment. Growing placebo response rates in schizophrenia trials can make treatment benefits harder to detect, potentially contributing to the sector’s drug development challenges. Credit: 9dream studio/Shutterstock.com. Unlock FREE Access to Premium Content Discover exclusive forecasts, analyst insights, and in-depth clinical trials industry analysis across drug development, clinical research, and trial innovation. With a free Clinical Trials Arena profile, you can: Experience unmatched clarity with a single platform…
A sector plagued by drug failures is looking to optimise study methodology, site selection, and patient recruitment.
Source: Clinical Trials Arena